Obesity influences the thresholds, but even in nonobese patients with dyspnea, optimal cutoffs may be lower than recommended.

A maladaptive stress response might be amenable to behavioral or other interventions to lower future CV risk, say researchers ...

This year’s report shows risk factors on the rise, enduring racial and geographic gaps, and clues to the global picture, too.

Task force members say that continued collection of data will help build credibility of what is “fair market value” for ...

New data from US centers suggest some overtesting in patients without chest pain, and undertesting in those who do.

The ability to diagnose MI was better with troponin I, but T better predicted mortality. Both tests have strengths, ...

Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.

These latest data reinforce years of smaller studies, but whether they should change practice is a matter of debate.

Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

A study suggests that those under age 65 may need no restrictions at all, but more data would help clarify the issue.

These documents have become too technical, too inconsistent, and rely too much on expert opinion, Marco Valgimigli argues.